Skip to main content

Advertisement

SpringerLink
Log in

Methylation of the INK4A/ARF locus in blood mononuclear cells

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

In the detection of DNA hypermethylation as a tumor-specific epigenetic change in blood mononuclear cell fraction in patients with lymphoid and hematopoetic disorders, circulating tumor cells originating from the lymph nodes or bone marrow can be identified. However, it is still not clear whether methylation in mononuclear cells is disease specific. In the present study, we investigated whether methylation of the inhibitor of cyclin-dependent kinase (INK) 4A/alternative reading frame (ARF) locus is present in a disease-specific manner in the blood mononuclear cell fraction of patients with lymphoma, multiple myeloma, or leukemia. To increase the sensitivity of detection, a two-step methylation-specific PCR approach was used to analyze the methylation status of the promoter/exon 1 regions of both p14ARF and p16INK4A genes. Our findings indicate that although INK4A/ARF locus methylation is present in mononuclear cells, this event is not disease-specific since normal subjects also display methylated DNA in their mononuclear cells. In 85.1% of the patients and in 89% of the controls, p16INK4A gene was methylated, while the methylation rates for the p14ARF gene was 32.6 and 36.5%, respectively. The presence of methylated CpG sites in DNA in samples from normal subjects was confirmed by bisulfite genomic sequencing. The difference in the methylation rate between p16INK4A and p14ARF genes among the patients was highly significant (p<0.001). Our results demonstrate that methylation of the INK4A/ARF locus is not a disease-specific molecular change in mononuclear cell fraction and that the p14ARF and p16INK4A genes are differentially methylated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Aggerholm A, Guldberg P, Hokland M, Hokland P (1999) Extensive intra-and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia. Cancer Res 59:436–441

    PubMed  CAS  Google Scholar 

  2. Ahuja N, Issa JP (2000) Aging, methylation and cancer. Histol Histopathol 15:835–842

    PubMed  CAS  Google Scholar 

  3. Baur AS, Shaw P, Burri N, Delacretaz F, Bosman FT, Chaubert P (1999) Frequent methylation silencing of p15(INK4b) (MTS2) and p16(INK4a) (MTS1) in B-cell and T-cell lymphomas. Blood 94:1773–1781

    PubMed  CAS  Google Scholar 

  4. Bhatia K, Siraj AK, Hussain A, Bu R, Gutierrez MI (2003) The tumor suppressor gene 14-3-3 sigma is commonly methylated in normal and malignant lymphoid cells. Cancer Epidemiol Biomarkers Prev 12:165–169

    PubMed  CAS  Google Scholar 

  5. Burri N, Shaw P, Bouzourene H, Sordat I, Sordat B, Gillet M, Schorderet D, Bosman FT, Haubert P (2001) Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab Invest 81:217–229

    PubMed  CAS  Google Scholar 

  6. Chalitchagorn K, Shuangshoti S, Hourpai N, Kongruttanachok N, Tangkijvanich P, Thong-ngam D, Voravud N, Sriuranpong V, Mutirangura A (2004) Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23:8841–8846

    Article  CAS  Google Scholar 

  7. Chen W, Wu Y, Zhu J, Liu J, Tan S, Xia C (2002) Methylation of p16 and p15 genes in multiple myeloma. Chin Med Sci J 17:101–105

    PubMed  CAS  Google Scholar 

  8. Chim CS, Tam CY, Liang R, Kwong YL (2001) Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance. Cancer 91:2222–2229

    Article  PubMed  CAS  Google Scholar 

  9. Chim CS, Wong AS, Kwong YL (2003) Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias. Ann Hematol 82:738–742

    Article  PubMed  CAS  Google Scholar 

  10. Corn PG, Kuerbitz SJ, van Noesel MM, Esteller M, Compitello N, Baylin SB, Herman JG (1999) Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt’s lymphoma is associated with 5’ CpG island methylation. Cancer Res 59:3352–3356

    PubMed  CAS  Google Scholar 

  11. Crawford YG, Gauthier ML, Joubel A, Mantei K, Kozakiewicz K, Afshari CA, Tlsty TD (2004) Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program. Cancer Cell 5:263–273

    Article  PubMed  CAS  Google Scholar 

  12. Das PM, Singal R (2004) DNA methylation and cancer. J Clin Oncol 22:4632–4542

    Article  PubMed  CAS  Google Scholar 

  13. Duro D, Bernard O, Della Valle V, Berger R, Larsen CJ (1995) A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies. Oncogene 1:21–29

    Google Scholar 

  14. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG (1999) Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59:67–70 (erratum in Cancer Res 1999 59:3853)

    PubMed  CAS  Google Scholar 

  15. Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G, Sidransky D, Meltzer SJ, Baylin SB, Herman JG (2000) Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 60:4366–4371

    PubMed  CAS  Google Scholar 

  16. Galm O, Herman JG (2005) Methylation-specific polymerase chain reaction. Methods Mol Med 113:279–291

    PubMed  CAS  Google Scholar 

  17. Goessl C, Muller M, Heicappell R, Krause H, Schostak M, Straub B, Miller K (2002) Methylation-specific PCR for detection of neoplastic DNA in biopsy washings. J Pathol 196:331–334

    Article  PubMed  CAS  Google Scholar 

  18. Guo SX, Taki T, Ohnishi H, Piao HY, Tabuchi K, Bessho F, Hanada R, Yanagisawa M, Hayashi Y (2000) Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia. Leuk Res 24:39–46

    Article  PubMed  CAS  Google Scholar 

  19. Gutierrez MI, Siraj AK, Bhargava M, Ozbek U, Banavali S, Chaudhary MA, El Solh H, Bhatia K (2003) Concurrent methylation of multiple genes in childhood ALL: correlation with phenotype and molecular subgroup. Leukemia 17:1845–1850

    Article  PubMed  CAS  Google Scholar 

  20. Hou P, Ji MJ, Shen JY, He NY, Lu ZH (2005) Detection of p16 hypermethylation in gastric carcinomas using a seminested methylation-specific PCR. Biochem Genet 43:1–9

    Article  PubMed  CAS  Google Scholar 

  21. Kramer A, Schultheis B, Bergmann J, Willer A, Hegenbart U, Ho AD, Goldschmidt H, Hehlmann R (2002) Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma. Leukemia 16:1844–1851

    Article  PubMed  CAS  Google Scholar 

  22. Kresty LA, Mallery SR, Knobloch TJ, Song H, Lloyd M, Casto BC, Weghorst CM (2002) Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Cancer Res 62:5295–5300

    PubMed  CAS  Google Scholar 

  23. Kuerbitz SJ, Pahys J, Wilson A, Compitello N, Gray TA (2002) Hypermethylation of the imprinted NNAT locus occurs frequently in pediatric acute leukemia. Carcinogenesis 23:559–564

    Article  PubMed  CAS  Google Scholar 

  24. Lehmann U, Langer F, Feist H, Glockner S, Hasemeier B, Kreipe H (2002) Quantitative assessment of promoter hypermethylation during breast cancer development. Am J Pathol 160:605–612

    PubMed  CAS  Google Scholar 

  25. Lehmann U, Berg-Ribbe I, Wingen LU, Brakensiek K, Becker T, Klempnauer J, Schlegelberger B, Kreipe H, Flemming P (2005) Distinct methylation patterns of benign and malignant liver tumors revealed by quantitative methylation profiling. Clin Cancer Res 11:3654–3660

    Article  PubMed  CAS  Google Scholar 

  26. Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ, Sidransky D (1995) A novel p16INK4A transcript. Cancer Res 55:2995–2997

    PubMed  CAS  Google Scholar 

  27. Muller HM, Widschwendter A, Fiegl H, Goebel G, Wiedemair A, Muller-Holzner E, Marth C, Widschwendter M (2004) A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancer. Cancer Lett 209:231–236

    Article  PubMed  CAS  Google Scholar 

  28. Nakamura M, Sakaki T, Hashimoto H, Nakase H, Ishida E, Shimada K, Konishi N (2001) Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas. Cancer Res 61:6335–6339

    PubMed  CAS  Google Scholar 

  29. Nguyen C, Liang G, Nguyen TT, Tsao-Wei D, Groshen S, Lubbert M, Zhou JH, Benedict WF, Jones PA (2001) Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells. J Natl Cancer Inst 93:1465–1472

    Article  PubMed  CAS  Google Scholar 

  30. Pao MM, Tsutsumi M, Liang G, Uzvolgyi E, Gonzales FA, Jones PA (2001) The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells. Hum Mol Genet 10:903–910

    Article  PubMed  CAS  Google Scholar 

  31. Reddy AN, Jiang WW, Kim M, Benoit N, Taylor R, Clinger J, Sidransky D, Califano JA (2003) Death-associated protein kinase promoter hypermethylation in normal human lymphocytes. Cancer Res 63:7694–7698

    PubMed  CAS  Google Scholar 

  32. Reddy J, Shivapurkar N, Takahashi T, Parikh G, Stastny V, Echebiri C, Crumrine K, Zochbauer-Muller S, Drach J, Zheng Y, Feng Z, Kroft SH, McKenna RW, Gazdar AF (2005) Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors. Oncogene 24:732–736

    Article  PubMed  CAS  Google Scholar 

  33. Remus R, Kanzaki A, Yawata A, Nakanishi H, Wada H, Sugihara T, Zeschnigk M, Zuther I, Schmitz B, Naumann F, Doerfler W, Yawata Y (2005) DNA methylation in promoter regions of red cell membrane protein genes in healthy individuals and patients with hereditary membrane disorders. Int J Hematol 8:385–395

    Article  CAS  Google Scholar 

  34. Rice JC, Ozcelik H, Maxeiner P, Andrulis I, Futscher BW (2000) Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis 21:1761–1765

    Article  PubMed  CAS  Google Scholar 

  35. Russo AL, Thiagalingam A, Pan H, Califano J, Cheng KH, Ponte JF, Chinnappan D, Nemani P, Sidransky D, Thiagalingam S (2005) Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer. Clin Cancer Res 11:2466–2470

    Article  PubMed  CAS  Google Scholar 

  36. Sakashita K, Koike K, Kinoshita T, Shiohara M, Kamijo T, Taniguchi S, Kubota T (2001) Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development. J Clin Invest 108:1195–1204

    Article  PubMed  CAS  Google Scholar 

  37. Takahashi T, Shivapurkar N, Reddy J, Shigematsu H, Miyajima K, Suzuki M, Toyooka S, Zochbauer-Muller S, Drach J, Parikh G, Zheng Y, Feng Z, Kroft SH, Timmons C, McKenna RW, Gazdar AF (2004) DNA methylation profiles of lymphoid and hematopoietic malignancies. Clin Cancer Res 10:2928–2935

    Article  PubMed  CAS  Google Scholar 

  38. Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C (2001) INK4a–ARF alterations and p53 mutations in hepatocellular carcinomas. Oncogene 20:7104–7109

    Article  PubMed  CAS  Google Scholar 

  39. Widschwendter A, Muller HM, Hubalek MM, Wiedemair A, Fiegl H, Goebel G, Mueller-Holzner E, Marth C, Widschwendter M (2004) Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer. Gynecol Oncol 93:407–416

    Article  PubMed  CAS  Google Scholar 

  40. Xu XL, Yu J, Zhang HY, Sun MH, Gu J, Du X, Shi DR, Wang P, Yang ZH, Zhu JD (2004) Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J Gastroenterol 10:3441–3454

    PubMed  CAS  Google Scholar 

  41. Youssef EM, Lotan D, Issa JP, Wakasa K, Fan YH, Mao L, Hassan K, Feng L, Lee JJ, Lippman SM, Hong WK, Lotan R (2004) Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis. Clin Cancer Res 10:1733–1742

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

This work was supported by the Istanbul University Research Fund (project no. 245/23082004). Hereby, we declare that the experiments comply with the current laws of Turkey inclusive of ethics approval.

Author information

Authors and Affiliations

  1. Department of Basic Oncology, Oncology Institute, Istanbul University, Istanbul, Turkey

    Ugur Deligezer, Ebru E. Akisik & Nejat Dalay

  2. Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey

    Nilgün Erten

  3. IU Oncology Institute, 34390, Capa/Istanbul, Turkey

    Nejat Dalay

Authors
  1. Ugur Deligezer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nilgün Erten
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ebru E. Akisik
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nejat Dalay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nejat Dalay.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deligezer, U., Erten, N., Akisik, E.E. et al. Methylation of the INK4A/ARF locus in blood mononuclear cells. Ann Hematol 85, 102–107 (2006). https://doi.org/10.1007/s00277-005-0041-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-005-0041-9

Keywords

Search

Navigation